GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 135 filers reported holding GENOMIC HEALTH INC in Q3 2016. The put-call ratio across all filers is 5.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $213,000 | -12.0% | 4,233 | -40.1% | 0.00% | -50.0% |
| Q4 2017 | $242,000 | +272.3% | 7,063 | +181.3% | 0.00% | – |
| Q2 2016 | $65,000 | +18.2% | 2,511 | +14.0% | 0.00% | – |
| Q1 2016 | $55,000 | -6.8% | 2,203 | +32.1% | 0.00% | – |
| Q4 2015 | $59,000 | -89.6% | 1,668 | -93.8% | 0.00% | -100.0% |
| Q3 2015 | $566,000 | +3229.4% | 26,753 | +4222.0% | 0.00% | – |
| Q2 2015 | $17,000 | +13.3% | 619 | +28.7% | 0.00% | – |
| Q1 2015 | $15,000 | 0.0% | 481 | +3.7% | 0.00% | – |
| Q4 2014 | $15,000 | 0.0% | 464 | -14.5% | 0.00% | – |
| Q3 2014 | $15,000 | -6.2% | 543 | -6.5% | 0.00% | – |
| Q2 2014 | $16,000 | +6.7% | 581 | 0.0% | 0.00% | – |
| Q1 2014 | $15,000 | -11.8% | 581 | +1.8% | 0.00% | – |
| Q4 2013 | $17,000 | -71.7% | 571 | -70.7% | 0.00% | -100.0% |
| Q3 2013 | $60,000 | +81.8% | 1,948 | +86.1% | 0.00% | – |
| Q2 2013 | $33,000 | – | 1,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,744,010 | $756,432,000 | 6.19% |
| EMORY UNIVERSITY | 30,319 | $1,953,000 | 1.54% |
| Copper Rock Capital Partners, LLC | 292,596 | $18,630,000 | 1.46% |
| DE BURLO GROUP INC | 73,600 | $4,740,000 | 1.06% |
| Eversept Partners, LP | 23,866 | $1,537,209 | 0.83% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 165,310 | $10,648,000 | 0.83% |
| Aurora Investment Counsel | 20,916 | $1,347,000 | 0.73% |
| Texas Children's | 8,035 | $518,000 | 0.72% |
| Capital Impact Advisors, LLC | 24,665 | $1,570,000 | 0.67% |
| Granahan Investment Management | 130,650 | $8,415,000 | 0.60% |